Access recorded conference sections presented by local and international experts
Testosterone and the prostate: Risk-benefits of testosterone therapy in hypogonadal men
Dr. Abraham Morgentaler talks about the paradigm shift regarding testosterone and prostate cancer. He highlights that there is no evidence that high testosterone causes prostate cancer. He presents research showing that low testosterone is not protective, and contrary to common belief, low testosterone is associated with high-grade prostate cancer.
Abraham Morgentaler, MD, FACS Founder, Men's Health Boston Associate Clinical Professor of Urology Harvard Medical School Boston, Massachusetts, USA